Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -210.30M | -201.68M | -185.41M | -170.74M | -161.34M |
| Total Depreciation and Amortization | 2.13M | 2.13M | 2.05M | 1.90M | 1.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.59M | 48.73M | 45.28M | 43.37M | 41.88M |
| Change in Net Operating Assets | 9.09M | 17.88M | 1.19M | 9.11M | 1.25M |
| Cash from Operations | -155.50M | -132.94M | -136.89M | -116.36M | -116.36M |
| Capital Expenditure | -3.85M | -3.70M | -2.90M | -2.25M | -921.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 144.19M | 136.83M | 143.32M | 108.99M | -126.09M |
| Cash from Investing | 140.34M | 133.13M | 140.42M | 106.74M | -127.01M |
| Total Debt Issued | 19.91M | 19.91M | 19.91M | 19.91M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.21M | 3.34M | 3.57M | 3.22M | 275.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -13.00K | -88.00K | -261.00K | -847.00K |
| Cash from Financing | 23.12M | 23.23M | 23.39M | 22.87M | 274.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.95M | 23.42M | 26.92M | 13.25M | 31.03M |